Latham & Watkins advised Bridge Investment Group; Paul, Weiss, Rifkind, Wharton & Garrison advised Apollo; Debevoise & Plimpton advised J.P. Morgan Securities, and Cravath, Swaine &...
Apollo’s $1.5 Billion Acquisition of Bridge
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Genpact’s $400 Million Senior Notes Offering
Cravath, Swaine & Moore advised Genpact Luxembourg S.à r.l. and Genpact USA, Inc. on the offering, and Simpson Thacher & Bartlett advised the underwriters. Genpact USA,...
T-Mobile’s Acquisition of UScellular’s Wireless Operations and Select Spectrum Assets
Cleary Gottlieb Steen & Hamilton and DLA Piper represented T-Mobile US Inc., Cravath, Swaine & Moore represented the independent directors of UScellular, Sidley Austin represented majority...
Gilead Sciences’ $4.3 Billion Acquisition of CymaBay Therapeutics
Davis Polk & Wardwell is advising Gilead Sciences, Inc. on the transaction, and Cravath, Swaine & Moore is advising CymaBay Therapeutics, Inc. Gilead Sciences, Inc. (Gilead)...